| For: | Gonczi L, Bessissow T, Lakatos PL. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by “tight control”? World J Gastroenterol 2019; 25(41): 6172-6189 [PMID: 31749591 DOI: 10.3748/wjg.v25.i41.6172] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i41/6172.htm |
| Number | Citing Articles |
| 1 |
Abdallah Kobeissy, Nooraldin Merza, Yusuf Nawras, Eshak I. Bahbah, Alsadiq Al-Hillan, Zohaib Ahmed, Mona Hassan, Yaseen Alastal. Evaluating the diagnostic accuracy of magnetic resonance imaging in distinguishing strictures in Crohn’s disease: a systematic review and meta-analysis. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04544-0
|
| 2 |
Parambir S. Dulai, Brian G. Feagan, Bruce E. Sands, Jingjing Chen, Karen Lasch, Richard A. Lirio. Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis. Clinical Gastroenterology and Hepatology 2023; 21(2) doi: 10.1016/j.cgh.2022.07.027
|
| 3 |
Alexandre Loktionov. Colon mucus in colorectal neoplasia and beyond. World Journal of Gastroenterology 2022; 28(32): 4475-4492 doi: 10.3748/wjg.v28.i32.4475
|
| 4 |
Dave Singh, MeiLan K. Han, Surya P. Bhatt, Marc Miravitlles, Chris Compton, Stefanie Kolterer, Tharishini Mohan, Suneal K. Sreedharan, Lee Tombs, David M. G. Halpin. Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?. American Journal of Respiratory and Critical Care Medicine 2025; 211(3) doi: 10.1164/rccm.202406-1254CI
|
| 5 |
Dahye Ryu, Hyun Jin Han, Junghyun Na, Seoyeon Choi, Young Mi Park, Hae Sun Suh. Patterns and factors associated with dose escalation during maintenance treatment for inflammatory bowel disease: a population-based cohort study. Sage Open Chronic Disease 2026; 17 doi: 10.1177/27558428261419710
|
| 6 |
J.K. Yamamoto-Furusho, N.N. Parra-Holguín. Real-world experience with MMX mesalazine use in Mexican patients with ulcerative colitis at two tertiary care centers. Revista de Gastroenterología de México (English Edition) 2022; 87(3) doi: 10.1016/j.rgmxen.2021.06.002
|
| 7 |
Marko Banić, Željko Krznarić, Marko Brinar, Marija Urek, Milenko Bevanda. Drug Interactions in Gastroenterology. Clinical Gastroenterology 2024; doi: 10.1007/978-3-031-69800-2_29
|
| 8 |
Piergiorgio Martella, Manuele Cesare, Silvia Cilluffo, Alessandro Monaci, Valentina Biagioli, Davide Bartoli, Daniele Napolitano, Antonello Cocchieri. Self‐Efficacy as a Mediator Between Medication Adherence and Self‐Care in Inflammatory Bowel Disease: A Multicenter Cross‐Sectional Study. Journal of Clinical Nursing 2026; doi: 10.1111/jocn.70385
|
| 9 |
Paulina Nuñez F, Uma Mahadevan, Rodrigo Quera, Constanza Bay, Patricio Ibañez. Treat-to-target approach in the management of inflammatory Bowel disease. Gastroenterología y Hepatología (English Edition) 2021; 44(4) doi: 10.1016/j.gastre.2020.06.023
|
| 10 |
Dora Grgić, Karlo Golubić, Marko Brinar, Željko Krznarić. Predictive value of faecal calprotectin in ulcerative colitis – single centre experience. Annals of Medicine 2022; 54(1) doi: 10.1080/07853890.2022.2082518
|
| 11 |
Antonio Facciorusso, Daryl Ramai, Cristina Ricciardelli, Rosa Paolillo, Marcello Maida, Saurabh Chandan, Babu P. Mohan, Viktor Domislovic, Rodolfo Sacco. Prognostic Role of Post-Induction Fecal Calprotectin Levels in Patients with Inflammatory Bowel Disease Treated with Biological Therapies. Biomedicines 2022; 10(9) doi: 10.3390/biomedicines10092305
|
| 12 |
Kanya K Shah, Aisling R Caffrey, Andy Szczotka, Dea Belazi, Stephen J Kogut. Real-world utilization of top-down and step-up therapy and initial costs in Crohn disease. Journal of Managed Care & Specialty Pharmacy 2022; 28(8) doi: 10.18553/jmcp.2022.28.8.849
|
| 13 |
Amirhosein Kefayat, Ross J Porter, Antonia MD Churchhouse, Jonathan Blackwell, Eleanor F Watson, Allan John Morris, Morris Gordon, Gaurav B Nigam, James E East, Matthew D Rutter, Christopher A Lamb, Tim Raine, Alexander C Ford, Shahida Din. Reduced risk of colorectal cancer with non-sulfasalazine 5-ASAs in ulcerative colitis and Crohn’s disease and anti-TNF therapy in ulcerative colitis: a systematic review and meta-analysis. Frontline Gastroenterology 2025; doi: 10.1136/flgastro-2025-103409
|
| 14 |
José María Paredes, Tomás Ripollés, Ángela Algarra, Rafael Diaz, Nadia Moreno, Patricia Latorre, María Jesús Martínez, Pilar Llopis, Antonio López, Eduardo Moreno-Osset. Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests. Intestinal Research 2022; 20(3) doi: 10.5217/ir.2021.00126
|
| 15 |
Alexandre Loktionov. Current approaches to disease severity and therapy effectiveness assessment in patients with inflammatory bowel disease. World Journal of Gastrointestinal Pharmacology and Therapeutics 2026; 17(2): 116608 doi: 10.4292/wjgpt.v17.i2.116608
|
| 16 |
Jack West, Katrina Tan, Jalpa Devi, Finlay Macrae, Britt Christensen, Jonathan P. Segal. Benefits and Challenges of Treat-to-Target in Inflammatory Bowel Disease. Journal of Clinical Medicine 2023; 12(19) doi: 10.3390/jcm12196292
|
| 17 |
Vito Annese, Peter L. Lakatos. A further “stri(v)de” in IBD management. Digestive and Liver Disease 2020; 52(7) doi: 10.1016/j.dld.2020.02.005
|
| 18 |
JiuJie Yang, Jerome P.L. Ng, Kaixi Zhang, Liang Liu, Vincent Kam Wai Wong. Rheumatoid Arthritis. 2022; doi: 10.5772/intechopen.99212
|
| 19 |
David Fenton, Natalie K Choi, Nicole M Garcia, Emma C Dyer, Nathaniel A Cohen, David T Rubin. Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project. Crohn's & Colitis 360 2022; 4(4) doi: 10.1093/crocol/otac042
|
| 20 |
Giulia D'Arcangelo, Chiara Imondi, Gianluca Terrin, Giulia Catassi, Marina Aloi. Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn Disease?. Journal of Pediatric Gastroenterology and Nutrition 2021; 73(2) doi: 10.1097/MPG.0000000000003151
|
| 21 |
Laurent Peyrin-Biroulet, William J. Sandborn, Remo Panaccione, Eugeni Domènech, Lieven Pouillon, Britta Siegmund, Silvio Danese, Subrata Ghosh. Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues. Therapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211059954
|
| 22 |
Paulina Nuñez F, Uma Mahadevan, Rodrigo Quera, Constanza Bay, Patricio Ibañez. Treat-to-target approach in the management of inflammatory Bowel disease. Gastroenterología y Hepatología 2021; 44(4) doi: 10.1016/j.gastrohep.2020.06.032
|
| 23 |
Thomai Tsapanou-Katranara, Marta S. Alexdottir, Majken Lindholm Olesen, Viktor Domislović, Anne-Christine Bay-Jensen, Morten Asser Karsdal, Željko Krznarić, Jens Kjeldsen, Mark A. Ainsworth, Joachim H. Mortensen. Neutrophil-mediated degradation of type III collagen is elevated in inflammatory bowel disease and DSS-induced colitis reflecting early mucosal damage. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-09043-6
|
| 24 |
Saifei Xu, Pingnan Zhang, Na Li, Jingjing Liu, Xiaotan Dou, Chenggong Yu. IFX Is Associated with Higher Rates of 2-Year Mucosal Healing in Biologic-Naïve CD Patients Compared to UST. Digestive Diseases and Sciences 2025; 70(12) doi: 10.1007/s10620-025-09226-1
|
| 25 |
舒 陈. Progress in Biomarkers of Inflammatory Bowel Disease. Advances in Clinical Medicine 2024; 14(03) doi: 10.12677/acm.2024.143860
|
| 26 |
Ondrej Fabian, Lukas Bajer, Pavel Drastich, Karel Harant, Eva Sticova, Nikola Daskova, Istvan Modos, Filip Tichanek, Monika Cahova. A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review. International Journal of Molecular Sciences 2023; 24(11) doi: 10.3390/ijms24119386
|
| 27 |
Cambrian Y. Liu, Candace M. Cham, Eugene B. Chang. Epithelial wound healing in inflammatory bowel diseases: the next therapeutic frontier. Translational Research 2021; 236 doi: 10.1016/j.trsl.2021.06.001
|
| 28 |
Annamária Polgár, Brigitta Szálka, Tamás Molnár, István Kósa, István Vassányi, Erzsébet Mák. A mobilapplikációval támogatott alacsony-FODMAP-étrend a funkcionális gastrointestinalis és a gyulladásos bélbetegségek kezelésében. Orvosi Hetilap 2022; 163(31) doi: 10.1556/650.2022.32502
|
| 29 |
Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon. Long‐term clinical outcomes of intestinal Behçet's disease: A 30‐year cohort study at a tertiary hospital in South Korea. Journal of Gastroenterology and Hepatology 2023; 38(3) doi: 10.1111/jgh.16056
|
| 30 |
Ashish R Srinivasan. Treat to target in Crohn’s disease: A practical guide for clinicians. World Journal of Gastroenterology 2024; 30(1): 50-69 doi: 10.3748/wjg.v30.i1.50
Abstract(973) |
Core Tip(1019) |
Full Article(HTML)(16020)
|
Full Article (PDF)-922K(1013)
|
Full Article with Cover (PDF)-2334K(482)
|
Full Article (Word)-573K(46)
|
Full Article (XML)-347K(207)
|
Audio-403K(41)
|
Peer-Review Report-232K(166)
|
Answering Reviewers-60K(154)
|
Times Cited (38)
|
Total Visits (19345)
|
Open
|
| 31 |
Dimitri Poddighe, Aigerim Telman, Ernas Tuleutayev, Aigul Ibrayeva. Pediatric Ulcerative Colitis in Kazakhstan: First Case Series from Central Asia and Current Clinical Management. Gastroenterology Insights 2020; 11(2) doi: 10.3390/gastroent11020006
|
| 32 |
Daniele Napolitano, Alessio Lo Cascio, Mattia Bozzetti, Fabrizio Benedetti, Giulia Petruccini, Francesco Petrosino, Silvia Cilluffo, Francesca Trotta, Davide Bartoli, Ercole Vellone, Gianluca Pucciarelli. Caregiver Contribution to Self-Care in Adults with Inflammatory Bowel Disease: A Cross-Sectional Multicenter Study. Nursing Reports 2026; 16(4) doi: 10.3390/nursrep16040110
|
| 33 |
Cristina Lanzotti, Mariangela Allocca, Alessandra Zilli, Ferdinando D’Amico, Virginia Solitano, Sara Massironi, Silvio Danese, Federica Furfaro. Integrating Intestinal Ultrasound in the Personalized Management of IBD. Journal of Personalized Medicine 2026; 16(4) doi: 10.3390/jpm16040199
|
| 34 |
Patricia Latorre Añó, Jorge Torrente Sánchez, Amparo Almudena Pérez Ibañez, Jose María Tenias Burillo, Nadia Paloma Moreno Sánchez, Antonio López-Serrano, Eduardo Moreno Osset, Julián Murado Pardo, José María Paredes. Fecal immunochemical test for haemoglobin versus fecal calprotectin to monitoring endoscopic activity in inflammatory bowel disease. Revista Española de Enfermedades Digestivas 2023; doi: 10.17235/reed.2023.9536/2023
|
| 35 |
D.C.R. Fernandes, H.J.N. Andreyev. Gastrointestinal Toxicity of Pelvic Radiotherapy: Are We Letting Women Down?. Clinical Oncology 2021; 33(9) doi: 10.1016/j.clon.2021.04.009
|
| 36 |
Karen Kemp, Pearl Avery, Ruby Bryant, Amanda Cross, Kayleigh Danter, Andrew Kneebone, Deborah Morris, Amy Walker, Lisa Whitley, Lesley Dibley. Clinical service delivery implications of the COVID-19 pandemic on people with Inflammatory bowel disease: a qualitative study. BMC Health Services Research 2023; 23(1) doi: 10.1186/s12913-023-10181-8
|
| 37 |
J.K. Yamamoto-Furusho, N.N. Parra-Holguín. Experiencia de la vida real con el uso de mesalazina MMX en pacientes mexicanos con CUCI en dos centros de tercer nivel. Revista de Gastroenterología de México 2022; 87(3) doi: 10.1016/j.rgmx.2021.01.010
|
| 38 |
Ferdinando D’Amico, Thomas Chateau, Valérie Laurent, Silvio Danese, Laurent Peyrin-Biroulet. Which MRI Score and Technique Should Be Used for Assessing Crohn’s Disease Activity?. Journal of Clinical Medicine 2020; 9(6) doi: 10.3390/jcm9061691
|
| 39 |
Vilk Janne da Silva Barros, Juliana Soares Severo, Pedro Henrique Moraes Mendes, Alda Cássia Alves da Silva, Kelly Beatriz Vieira de Oliveira, José Miguel Luz Parente, Murilo Moura Lima, Emídio Marques Matos Neto, Armênio Aguiar dos Santos, Moisés Tolentino Bento da Silva. Effect of dietary interventions on inflammatory biomarkers of inflammatory bowel diseases: A systematic review of clinical trials. Nutrition 2021; doi: 10.1016/j.nut.2021.111457
|
| 40 |
Malik Kasapoglu, Rajesh Yadavalli, Sarosh Nawaz, Abdulaziz Althwanay, Esraa M AlEdani, Harleen Kaur, Samia Butt. The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review. Cureus 2024; doi: 10.7759/cureus.60786
|
| 41 |
Alessandro Vitello, Marcello Maida, Endrit Shahini, Fabio Salvatore Macaluso, Ambrogio Orlando, Mauro Grova, Daryl Ramai, Gaetano Serviddio, Antonio Facciorusso. Current Approaches for Monitoring of Patients with Inflammatory Bowel Diseases: A Narrative Review. Journal of Clinical Medicine 2024; 13(4) doi: 10.3390/jcm13041008
|